Project Number 1R01AG065248-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for COG0202; A Randomized Double Blind; Placebo Controlled; Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator CATALANO, SUSAN M Principal Investigator First Name SUSAN Principal Investigator Last Name CATALANO Awardee Organization Cognition Therapeutics, Inc. Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-513: Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) FY Overall Cost $24,386,639 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
